ACM, BAVA get smallpox contracts

As expected, the NIH's National Institute of Allergy and Infectious Diseases awarded two smallpox Modified Vaccinia Ankara (MVA) vaccine contracts to Acambis

Read the full 229 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE